Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT04976946




Registration number
NCT04976946
Ethics application status
Date submitted
15/07/2021
Date registered
26/07/2021
Date last updated
17/10/2022

Titles & IDs
Public title
Protocol for CAMUS Delphi Study
Scientific title
Protocol for CAMUS Delphi Study: A Consensus on Reporting of Complications After Urological Surgeries
Secondary ID [1] 0 0
2020.046
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Complications; Urogenital, Postprocedural 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Other interventions - Comprehensive questionnaire

Urologists - Local and international consultant Urologists and accredited Urology trainees.

Anaesthetists - Local and international consultant anaesthetists. Critical care physicians who are primarily Urological anaesthetists or have experience in complication reporting will be targeted.

ICU specialists - Local and international consultant ICU specialists. Critical care physicians who are primarily Urological focused or have experience in complication reporting will be targeted.


Other interventions: Comprehensive questionnaire
Multi-staged, international Delphi study that aims to establish criteria for standardised complication reporting in Urology.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Standardised complication reporting in Urology
Timepoint [1] 0 0
6 months

Eligibility
Key inclusion criteria
- Local and international consultant Urologists, accredited Urology trainees, consultant
Anaesthetists and consultant ICU specialists will be invited to complete the survey.
Critical care physicians who are primarily Urological anaesthetists or have experience
in complication reporting will be targeted.
Minimum age
18 Years
Maximum age
100 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
- All other specialists that do not meet the inclusion criteria.

- Under 18 years of age.

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
12/08/2021
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/12/2023
Actual
Sample size
Target
750
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
The Royal Melbourne Hospital - Melbourne
Recruitment postcode(s) [1] 0 0
- Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
Melbourne Health
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Multi-staged, international Delphi study that aims to establish criteria for standardised
complication reporting in Urology.
Trial website
https://clinicaltrials.gov/ct2/show/NCT04976946
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Marc A Furrer, MD
Address 0 0
Melbourne Health
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT04976946